On behalf of The Transplantation Society, at the 75th World Health Assembly in Geneva, Switzerland, President Marcelo Cantarovich delivered a statement to WHO and international delegates from around the world addressing the WHO Progress Report Human organ and tissue transplantation: https://apps.who.int/gb/ebwha/pdf_files/WHA75/A75_41-en.pdf
View the video recording of TTS’ statement here: https://www.who.int/about/governance/world-health-assembly/seventy-fifth-world-health-assembly. You may also read TTS’ statement here: TTS_statement_WHA75.pdf and the statement of Spain, supported by 36 member states, Statement_75_WHA_Transplantation.pdf calling for continued WHO efforts and a renewed WHA Resolution on transplantation.
We look forward to continuing to collaborate with the WHO and nation states to advance transplantation around the world.
Packed full of interest for everyone, this issue ranges from a new islet isolation system and better machine perfusion techniques, to long term consequences and risk factors in pancreas, lung, heart and liver transplantation. A brilliant review of tissue resident memory T Cells is just one of a number of fascinating basic science papers this month. Pregnancy after kidney transplantation remains an important goal for many patients and this issue has useful data and advice for those counselling such patients.
CLICK HERE TO ACCESS THIS ISSUE
TTS MEMBERS - CLICK HERE TO SIGN-IN FOR OPEN ACCESS THROUGH TTS.ORG
In accordance with our bylaws we are holding a by-election for the Vice President (2022-2026) position being vacated by John Fung. We will hold a short call for nomination period (May 20 to June 3, 2022) followed by an election period from June 7 to 27, 2022.
Click the button below to see all eligible candidates.
Check out the program preview available on our website!
Repairing and Regenerating Organs for Transplantation Has Become a Reality #TBTThe research described in this issue of Transplantation and summarized in the commentary by Baan highlights the latest developments in the field of tissue engineering, repair and regeneration for organ transplantation.
Clinical Validation of a Plasma Donor-derived Cell-free DNA Assay to Detect Allograft Rejection and Injury in Lung Transplant #OpenAccess #TransplantTwitterLung transplant patients are vulnerable to various forms of allograft injury, whether from acute rejection (AR) (encompassing acute cellular rejection [ACR] and antibody-mediated rejection [AMR]), chronic lung allograft dysfunction (CLAD), or infection (INFXN). Previous research indicates that donor-derived cell-free DNA (dd-cfDNA) is a promising noninvasive biomarker for the detection of AR and allograft injury. Our aim was to validate a clinical plasma dd-cfDNA assay for detection of AR and other allograft injury and to confirm and expand on dd-cfDNA and allograft injury associations observed in previous studies.
In-Person and Virtual
Max Dubernard: In Memoriam – The Legend of Lyon - Warren Breidenbach
Xenotransplantation – Implications for VCA - Robert Montgomery
Dr. Anette Melk (WIT Pillar 2) will lead a session on Sex, age and hormone interactions in transplantation outcomes in children on Sunday June 19th at 16:00 local time. Astellas are proud to sponsor a WIT Networking lunch on Monday June 20th from 12:40pm to 13:35.
WIT members who are registered for and attending TSANZ will receive complimentary registration for the Networking session. Please note that access to the WIT Networking lunch is only open to those registered for the TSANZ meeting.
The Transplantation Society
740 Notre-Dame Ouest
Montréal, QC, H3C 3X6